STROGAR - STrengthening the Reporting of Genetic Association studies in RadiogenomicsCitation formats

  • External authors:
  • Sarah L. Kerns
  • Dirk De Ruysscher
  • Christian N. Andreassen
  • David Azria
  • Gillian C. Barnett
  • Jenny Chang-Claude
  • Susan Davidson
  • Joseph O. Deasy
  • Alison M. Dunning
  • Harry Ostrer
  • Barry S. Rosenstein
  • Søren M. Bentzen

Standard

STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics. / Kerns, Sarah L.; Ruysscher, Dirk De; Andreassen, Christian N.; Azria, David; Barnett, Gillian C.; Chang-Claude, Jenny; Davidson, Susan; Deasy, Joseph O.; Dunning, Alison M.; Ostrer, Harry; Rosenstein, Barry S.; West, Catharine M L; Bentzen, Søren M.

In: Radiotherapy and Oncology, Vol. 110, No. 1, 2014, p. 182-188.

Research output: Contribution to journalArticlepeer-review

Harvard

Kerns, SL, Ruysscher, DD, Andreassen, CN, Azria, D, Barnett, GC, Chang-Claude, J, Davidson, S, Deasy, JO, Dunning, AM, Ostrer, H, Rosenstein, BS, West, CML & Bentzen, SM 2014, 'STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics', Radiotherapy and Oncology, vol. 110, no. 1, pp. 182-188. https://doi.org/10.1016/j.radonc.2013.07.011

APA

Kerns, S. L., Ruysscher, D. D., Andreassen, C. N., Azria, D., Barnett, G. C., Chang-Claude, J., Davidson, S., Deasy, J. O., Dunning, A. M., Ostrer, H., Rosenstein, B. S., West, C. M. L., & Bentzen, S. M. (2014). STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics. Radiotherapy and Oncology, 110(1), 182-188. https://doi.org/10.1016/j.radonc.2013.07.011

Vancouver

Kerns SL, Ruysscher DD, Andreassen CN, Azria D, Barnett GC, Chang-Claude J et al. STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics. Radiotherapy and Oncology. 2014;110(1):182-188. https://doi.org/10.1016/j.radonc.2013.07.011

Author

Kerns, Sarah L. ; Ruysscher, Dirk De ; Andreassen, Christian N. ; Azria, David ; Barnett, Gillian C. ; Chang-Claude, Jenny ; Davidson, Susan ; Deasy, Joseph O. ; Dunning, Alison M. ; Ostrer, Harry ; Rosenstein, Barry S. ; West, Catharine M L ; Bentzen, Søren M. / STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics. In: Radiotherapy and Oncology. 2014 ; Vol. 110, No. 1. pp. 182-188.

Bibtex

@article{fe75244167424ba8aa46d008a6198dc9,
title = "STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics",
abstract = "Despite publication of numerous radiogenomics studies to date, positive single nucleotide polymorphism (SNP) associations have rarely been reproduced in independent validation studies. A major reason for these inconsistencies is a high number of false positive findings because no adjustments were made for multiple comparisons. It is also possible that some validation studies were false negatives due to methodological shortcomings or a failure to reproduce relevant details of the original study. Transparent reporting is needed to ensure these flaws do not hamper progress in radiogenomics. In response to the need for improving the quality of research in the area, the Radiogenomics Consortium produced an 18-item checklist for reporting radiogenomics studies. It is recognised that not all studies will have recorded all of the information included in the checklist. However, authors should report on all checklist items and acknowledge any missing information. Use of STROGAR guidelines will advance the field of radiogenomics by increasing the transparency and completeness of reporting. {\textcopyright} 2013 Elsevier Ireland Ltd. All rights reserved.",
keywords = "Genetics, Normal tissue toxicity, Radiogenomics, Reporting guidelines",
author = "Kerns, {Sarah L.} and Ruysscher, {Dirk De} and Andreassen, {Christian N.} and David Azria and Barnett, {Gillian C.} and Jenny Chang-Claude and Susan Davidson and Deasy, {Joseph O.} and Dunning, {Alison M.} and Harry Ostrer and Rosenstein, {Barry S.} and West, {Catharine M L} and Bentzen, {S{\o}ren M.}",
note = "R01 CA134444, NCI NIH HHS, United States",
year = "2014",
doi = "10.1016/j.radonc.2013.07.011",
language = "English",
volume = "110",
pages = "182--188",
journal = "Radiotherapy & Oncology",
issn = "0167-8140",
publisher = "Elsevier BV",
number = "1",

}

RIS

TY - JOUR

T1 - STROGAR - STrengthening the Reporting of Genetic Association studies in Radiogenomics

AU - Kerns, Sarah L.

AU - Ruysscher, Dirk De

AU - Andreassen, Christian N.

AU - Azria, David

AU - Barnett, Gillian C.

AU - Chang-Claude, Jenny

AU - Davidson, Susan

AU - Deasy, Joseph O.

AU - Dunning, Alison M.

AU - Ostrer, Harry

AU - Rosenstein, Barry S.

AU - West, Catharine M L

AU - Bentzen, Søren M.

N1 - R01 CA134444, NCI NIH HHS, United States

PY - 2014

Y1 - 2014

N2 - Despite publication of numerous radiogenomics studies to date, positive single nucleotide polymorphism (SNP) associations have rarely been reproduced in independent validation studies. A major reason for these inconsistencies is a high number of false positive findings because no adjustments were made for multiple comparisons. It is also possible that some validation studies were false negatives due to methodological shortcomings or a failure to reproduce relevant details of the original study. Transparent reporting is needed to ensure these flaws do not hamper progress in radiogenomics. In response to the need for improving the quality of research in the area, the Radiogenomics Consortium produced an 18-item checklist for reporting radiogenomics studies. It is recognised that not all studies will have recorded all of the information included in the checklist. However, authors should report on all checklist items and acknowledge any missing information. Use of STROGAR guidelines will advance the field of radiogenomics by increasing the transparency and completeness of reporting. © 2013 Elsevier Ireland Ltd. All rights reserved.

AB - Despite publication of numerous radiogenomics studies to date, positive single nucleotide polymorphism (SNP) associations have rarely been reproduced in independent validation studies. A major reason for these inconsistencies is a high number of false positive findings because no adjustments were made for multiple comparisons. It is also possible that some validation studies were false negatives due to methodological shortcomings or a failure to reproduce relevant details of the original study. Transparent reporting is needed to ensure these flaws do not hamper progress in radiogenomics. In response to the need for improving the quality of research in the area, the Radiogenomics Consortium produced an 18-item checklist for reporting radiogenomics studies. It is recognised that not all studies will have recorded all of the information included in the checklist. However, authors should report on all checklist items and acknowledge any missing information. Use of STROGAR guidelines will advance the field of radiogenomics by increasing the transparency and completeness of reporting. © 2013 Elsevier Ireland Ltd. All rights reserved.

KW - Genetics

KW - Normal tissue toxicity

KW - Radiogenomics

KW - Reporting guidelines

U2 - 10.1016/j.radonc.2013.07.011

DO - 10.1016/j.radonc.2013.07.011

M3 - Article

C2 - 23993398

VL - 110

SP - 182

EP - 188

JO - Radiotherapy & Oncology

JF - Radiotherapy & Oncology

SN - 0167-8140

IS - 1

ER -